Lipoprotein cholesterol and atherosclerosis
- PMID: 11899253
- DOI: 10.2174/1566524013363212
Lipoprotein cholesterol and atherosclerosis
Abstract
Progressive accumulation of cholesterol in the arterial wall causes atherosclerosis, the pathologic process underlying most heart attacks and strokes. Low density lipoprotein (LDL), the major carrier of blood cholesterol, has been implicated in the buildup of cholesterol in atherosclerotic plaques. Endothelial cells that line arteries function to transport LDL into the vessel wall. Models for the mechanism of cholesterol accumulation in atherosclerotic plaques emphasize increased LDL uptake into the vessel wall or increased retention of LDL that has entered the vessel wall. This article reviews the pathways of cholesterol entry and removal, the metabolism, and the physical changes of cholesterol in the vessel wall. How these processes are believed to contribute to cholesterol buildup in atherosclerotic plaques is discussed.
Similar articles
-
[Cellular and molecular bases of cholesterol accumulation in the vascular wall and its contribution to the progression of atherosclerotic lesion].Rev Esp Cardiol. 1998 Aug;51(8):633-41. doi: 10.1016/s0300-8932(98)74802-x. Rev Esp Cardiol. 1998. PMID: 9780777 Review. Spanish.
-
The fate of lipoprotein cholesterol entering the arterial wall.Curr Opin Lipidol. 1997 Oct;8(5):246-52. doi: 10.1097/00041433-199710000-00002. Curr Opin Lipidol. 1997. PMID: 9335947 Review.
-
Biochemistry of the arterial wall in developing atherosclerosis.Ann N Y Acad Sci. 1991;623:40-59. doi: 10.1111/j.1749-6632.1991.tb43717.x. Ann N Y Acad Sci. 1991. PMID: 2042847 Review. No abstract available.
-
Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white Carneau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis.Arterioscler Thromb. 1993 Sep;13(9):1368-81. doi: 10.1161/01.atv.13.9.1368. Arterioscler Thromb. 1993. PMID: 8364021
-
The inflow rate of low density lipoprotein cholesterol to the arterial wall in experimental atherosclerosis.Physiol Bohemoslov. 1986;35(4):313-8. Physiol Bohemoslov. 1986. PMID: 2945214
Cited by
-
Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis.Br J Clin Pharmacol. 2017 Jan;83(1):152-162. doi: 10.1111/bcp.13002. Epub 2016 Jun 17. Br J Clin Pharmacol. 2017. PMID: 27151091 Free PMC article. Review.
-
Biochemical effects, hypolipidemic and anti-inflammatory activities of Artemisia vulgaris extract in hypercholesterolemic rats.J Clin Biochem Nutr. 2015 Jul;57(1):33-8. doi: 10.3164/jcbn.14-141. Epub 2015 Apr 18. J Clin Biochem Nutr. 2015. PMID: 26236098 Free PMC article.
-
Cholesterol and Kir channels.IUBMB Life. 2009 Aug;61(8):781-90. doi: 10.1002/iub.192. IUBMB Life. 2009. PMID: 19548316 Free PMC article. Review.
-
Phytochemistry and pharmacological activity of the genus artemisia.Arch Pharm Res. 2021 May;44(5):439-474. doi: 10.1007/s12272-021-01328-4. Epub 2021 Apr 24. Arch Pharm Res. 2021. PMID: 33893998 Free PMC article. Review.
-
Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB.J Inflamm (Lond). 2015 Jan 20;12(1):1. doi: 10.1186/s12950-014-0044-1. eCollection 2015. J Inflamm (Lond). 2015. PMID: 25632270 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical